Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the month of October 2016, with the report signed on October 10, 2016. The document serves as a report of foreign private issuer transactions pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934. The content is strictly limited to a consolidated report of securities and derivatives transactions by the company's Board of Directors, Management, and Fiscal Council during September 2016, in compliance with Article 11 of CVM Instruction # 358/2002.
Key Financial Metrics
The filing text does not provide company-wide financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document exclusively details insider trading activity. The only financial values present relate to specific transaction volumes:
- Management Transactions: Two separate transactions involving 2,300 Common Shares each were recorded as "Donation" operations on September 6, 2016. The price was R$ 5.24 per share, with a total volume of R$ 12,052.00 per transaction.
- Board of Directors Transactions: A purchase of 63,004 Deferred ADRs occurred on September 28, 2016, directly with the company. The price was USD 0.94047 per ADR, with a total volume of USD 59,253.37.
- Fiscal Council Transactions: No transactions were reported; the balance remained at 7,225 Common Shares.
Material Changes Versus Prior Period
The filing does not provide comparative financial data against prior periods. Regarding insider holdings:
- Management: The total quantity of Common Shares held remained unchanged at 7,289,786 (0.0464% of total shares) and ADRs at 1,271,100 (0.0081%) after the reported donation transactions.
- Board of Directors: The holding of Deferred ADRs increased from 556,329 to 619,333 (0.0039% of total shares) following the purchase of 63,004 units. Common share holdings remained constant at 26,529,315.
- Fiscal Council: No change in holdings was reported.
Guidance, Outlook, and Risks
The filing text does not provide any management commentary, forward-looking guidance, outlook, risk factors, contingencies, or discussion of unusual items. The document is a statutory disclosure of insider trading activity only.
Important Facts for Investor Verification
- Verify the nature of the "Donation" transactions by Management to ensure compliance with internal policies and tax regulations.
- Confirm the source of funds for the Board of Directors' purchase of 63,004 Deferred ADRs directly from the company.
- Note that this filing contains no operational or financial performance data for Ambev S.A. for the period ending December 31, 2016, or September 2016.
- Check the total share count percentages to understand the relative size of insider holdings (Board: ~0.17%, Management: ~0.05%).